Toroso Investments, LLC Mereo Biopharma Group PLC Transaction History

Toroso Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.19 - $2.42 $14,903 - $30,308	-12,524 Reduced 3.77%	319,390 $737,000
Q1 2023 May 15, 2023	BUY	$0.71 - $1.22 $13,338 - $22,918	18,786 Added 6.0%	331,914 $235,000
Q4 2022 Feb 15, 2023	BUY	$0.5 - $1.01 $15,655 - $31,623	31,310 Added 11.11%	313,128 $235,000
Q3 2022 Nov 23, 2022	BUY	$0.82 - $1.73 $5,134 - $10,833	6,262 Added 2.27%	281,818 $243,000
Q2 2022 Aug 15, 2022	BUY	$0.33 - $1.69 $90,933 - $465,689	275,556 New	275,556 $309,000

107M

209K

479K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $376M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Toroso Investments, LLC with notifications on news.